• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

FDA approves new B&L contact lens material

Article

The FDA has cleared the use of the new Bausch & Lomb (B&L) Boston XO2 gas-permeable contact lens material for daily wear in patients with ametropia and certain irregular corneal conditions, the company announced.

Rochester, NY-The FDA has cleared the use of the new Bausch & Lomb (B&L) Boston XO2 gas-permeable contact lens material for daily wear in patients with ametropia and certain irregular corneal conditions, the company announced.

Lenses made with this new contact lens material allow 40% more oxygen to reach the eye than the original Boston XO material, said the eye-care company, which is being acquired by Warburg Pincus

Related Videos
© 2024 MJH Life Sciences

All rights reserved.